Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo
- 19 February 2011
- journal article
- Published by Springer Nature in Apoptosis
- Vol. 16 (5) , 511-523
Abstract
Artemisinin, the active principle of the Chinese medicinal herb Artemisia annua, and its derivatives (i.e. dihydroartemisinin, DHA) were reported to exhibit anti-tumor activity both in vitro and in vivo. The purpose of the present study was to investigate the functional role of Mitogen-Activated Protein Kinase (MEK)/Extracellular signal-regulated protein Kinase (ERK) signaling cascade in dihydroartemisinin (DHA)-induced apoptosis in human leukemia cells in vitro and anti-leukemic activity in vivo. Human leukemia cells were treated with DHA in dose- and time-dependent manners, after which apoptosis, caspase activation, Mcl-1 expression, and cell signaling pathways were evaluated. Parallel studies were performed in AML and ALL primary human leukemia cells. In vivo anti-leukemic activity mediated by DHA was also investigated using U937 xenograft mouse model. Exposure of DHA resulted in a pronounced increase in apoptosis in both transformed and primary human leukemia cells but not in normal peripheral blood mononuclear cells. DHA-induced apoptosis was accompanied by caspase activation, cytochrome c release, Mcl-1 down-regulation, as well as MEK/ERK inactivation. Pretreatment with MEK inhibitor PD98059, which potentiated DHA-mediated MEK and ERK inactivation, intensified DHA-mediated apoptosis. Conversely, enforced expression of a constitutively active MEK1 attenuated DHA-induced apoptosis. Furthermore, DHA-mediated inhibition of tumor growth of mouse U937 xenograft was associated with induction of apoptosis and inactivation of ERK. The findings in the present study showed that DHA-induced apoptosis in human leukemia cells in vitro and exhibited an anti-leukemic activity in vivo through a process that involves MEK/ERK inactivation, Mcl-1 down-regulation, culminating in cytochrome c release and caspase activation.Keywords
This publication has 48 references indexed in Scilit:
- Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cellsCancer Biology & Therapy, 2010
- Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitroCancer Chemotherapy and Pharmacology, 2009
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008
- Clinical Pharmacology of Artemisinin-Based Combination TherapiesClinical Pharmacokinetics, 2008
- The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivoAntiviral Research, 2006
- Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the ratCancer Letters, 2006
- Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative systemAntiviral Research, 2005
- Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegalovirusesJournal of Molecular Medicine, 2001
- Susceptibility of Pneumocystis carinii to artemisinin in vitroAntimicrobial Agents and Chemotherapy, 1991
- Inhibition of growth of Toxoplasma gondii by qinghaosu and derivativesAntimicrobial Agents and Chemotherapy, 1990